**UNITED
      STATES SECURITIES AND EXCHANGE COMMISSION**


**Washington,
      D.C. 20549**




**FORM
      10-QSB**


**(Mark
      One)**




**x**
            **Quarterly
                Report Pursuant to Section 13 or 15(d) of the Securities Exchange
                Act of
                1934.**




**For
      the quarterly period ended March 31, 2007**


**or**




**o**
            **Transition
                Report Pursuant to Section 13 or 15(d) of the Securities Exchange
                Act of
                1934.**




**For
      the transition period from ______to______.**




**Commission
      file number 000-50354**




**AMERICAN
      SURGICAL HOLDINGS, INC.**


(Exact
      name of registrant as specified in its charter)





**Delaware**
            **98-0403551**(State
                or other jurisdiction of
            (I.R.S.
                Employer Identification No.)incorporation
                or organization)**10039
                Bissonnet #250**
              **Houston,
                Texas**
            **77036-7852**(Address
                of principal executive offices)
            (Zip
                Code)




**(713)
      779-9800**


(Registrant’s
      telephone number, including area code)




(Former
      name, former address and former fiscal year, if changed since last
      report)




Check
        whether the issuer (1) has filed all reports required to be filed by Section
        13
        or 15(d) of the Exchange Act during the preceding 12 months (or for such
        shorter
        period that the issuer was required to file such reports), and (2) has been
        subject to such filing requirements for the past 90 days. Yes o No o
  Indicate
        by check mark whether the registrant is a shell company as defined in Rule
        12b-2
        of the Exchange Act. Yes o No o
 
 As
        of May
        10, 2007 there were 8,425,484 shares of common stock issued and
        outstanding.











**AMERICAN
      SURGICAL HOLDINGS, INC.**


**FORM
      10QSB**


**MARCH
      31, 2007**





**INDEX**




**PART
        I-- FINANCIAL INFORMATION**
  Item
                  1.
              Financial
                  StatementsItem
                  2.
              Management’s
                  Discussion and Analysis of Financial ConditionItem
                  3.
              Control
                  and Procedures
  **PART
        II-- OTHER INFORMATION**
  Item
                  1A.
              Risk
                  FactorsItem
                  2.
              Unregistered
                  Sales of Equity Securities and Use of ProceedsItem
                  3.
              Defaults
                  Upon Senior SecuritiesItem
                  4.
              Submission
                  of Matters to a Vote of Security HoldersItem
                  5.
              Other
                  InformationItem
                  6.
              Exhibits
                  and Reports on Form 8-K
  **SIGNATURE**




**Item
      1. Financial Information**




**AMERICAN
        SURGICAL HOLDINGS, INC. AND SUBSIDIARIES**
 **(formerly
        ASAH Corp.)**
 **CONDENSED
        CONSOLIDATED FINANCIAL STATEMENTS**
 **AS
        OF MARCH 31, 2007**
 **(UNAUDITED)**
 
  
 
 
 
 **AMERICAN
        SURGICAL HOLDINGS, INC. AND SUBSIDIARIES**
 **(formerly
        ASAH Corp.)**
 
 
 
 **CONTENTS**
 
 
 PAGE
              F1
              CONDENSED
                  CONSOLIDATED BALANCE SHEETS AS OF MARCH 31, 2007 (UNAUDITED) AND
                  DECEMBER
                  31, 2006 (AUDITED)PAGE
              F2
              CONDENSED
                  CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE MONTHS ENDED
                  MARCH 31,
                  2007 AND 2006  (UNAUDITED)PAGE
              F3
              CONDENSED
                  CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY (UNAUDITED)PAGE
              F4
              CONDENSED
                  CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE THREE MONTHS ENDED
                  MARCH 31,
                  2007 AND 2006 (UNAUDITED)PAGES
              F5
                  - F9
              NOTES
                  TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)











**AMERICAN
        SURGICAL HOLDINGS, INC. AND SUBSIDIARIES**
 **(formerly
        ASAH Corp.)**
 **CONDENSED
        CONSOLIDATED BALANCE SHEETS**
 **AS
        OF MARCH 31, 2007 AND DECEMBER 31, 2006**


**ASSETS**MARCH
                  31, 2007
                (UNAUDITED)
              
              DECEMBER
                  31,
                2006
                (AUDITED)**CURRENT
                  ASSETS**Cash
                  and cash equivalents
              
              $
              987,974
              
              $
              1,387,016Accounts
                  receivable, net
              
              
              2,018,847
              
              
              2,031,769Prepaid
                  expenses and other current assets
              
              
              47,054
              
              
              61,902**TOTAL
                  CURRENT ASSETS**
              
              
              3,053,875
              
              
              3,480,687**PROPERTY
                  AND EQUIPMENT, NET**
              
              
              100,753
              
              
              102,129**TOTAL
                  ASSETS**
              
              $
              3,154,628
              
              $
              3,582,816**LIABILITIES
                  AND STOCKHOLDERS’ EQUITY****CURRENT
                  LIABILITIES**Accounts
                  payable and accrued expenses
              
              $
              359,791
              
              $
              297,597Accrued
                  income tax payable
              
              
              115,082
              
              
              466,492Deferred
                  income tax
              
              
              512,178
              
              
              651,827**TOTAL
                  CURRENT LIABILITIES**
              
              
              987,051
              
              
              1,415,916**STOCKHOLDERS’
                  EQUITY**Preferred
                  stock, $0.001 par value, 10,000,000 shares authorized, none issued
                  and
                  outstanding
              
              
              -
              
              
              -Common
                  stock, $0.001 par value, 100,000,000 shares authorized, 8,425,484
                  and
                  8,300,484 shares issued and outstanding, respectively
              
              
              8,425
              
              
              8,300Additional
                  paid-in capital
              
              
              1,056,455
              
              
              513,143Deferred
                  compensation
              
              
              (598,327
              )
              
              (193,750
              )Retained
                  earnings
              
              
              1,701,024
              
              
              1,839,207Total
                  Stockholders’ Equity
              
              
              2,167,577
              
              
              2,166,900**TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY**
              
              $
              3,154,628
              
              $
              3,582,816




See
        accompanying notes to condensed consolidated financial
        statements.




F1




**AMERICAN
        SURGICAL HOLDINGS, INC. AND SUBSIDIARIES**
 **(formerly
        ASAH Corp.)**
 **CONDENSED
        CONSOLIDATED STATEMENTS OF OPERATIONS**
 **FOR
        THE THREE MONTHS ENDED**
 **(UNAUDITED)**




MARCH
                  31,
                2007
              
              MARCH
                  31,
                2006**REVENUES,
                  NET**
              
              $
              2,571,275
              
              $
              2,235,926**COST
                  OF REVENUES**
              
              
              1,598,601
              
              
              1,526,847**GROSS
                  PROFIT**
              
              
              972,674
              
              
              709,079**OPERATING
                  EXPENSES**
              
              
              1,147,075
              
              
              276,439**NET
                  (LOSS) INCOME FROM OPERATIONS**
              
              
              (174,401
              )
              
              432,640**OTHER
                  INCOME**
              
              
              5,484
              
              
              999**(LOSS)
                  INCOME FROM OPERATIONS**
              
              
              (168,917
              )
              
              433,639Provision
                  for Income Taxes
              
              
              (30,734
              )
              
              173,244**NET
                  (LOSS) INCOME**
              
              $
              (138,183
              )
              $
              260,395Net
                  (loss) income per share - basic and diluted
              
              $
              (.02
              )
              $
              .03Weighted average number of shares outstanding during the period
                  - basic
                  and diluted
              
              
              8,387,428
              
              
              8,289,457






See
      accompanying notes to condensed consolidated financial statements.






F2




**AMERICAN
        SURGICAL HOLDINGS, INC. AND SUBSIDIARIES**
 **(formerly
        ASAH Corp.)**
 **CONDENSED
        CONSOLIDATED STATEMENT OF STOCKHOLDERS EQUITY**
 **FOR
        THE PERIOD ENDED MARCH 31, 2007**
 **(UNAUDITED)**






Preferred
                  Stock
              
              Common
                  Stock
              
              Additional
                  Paid-In
              
              Deferred
              
              RetainedShares
              
              Amount
              
              Shares
              
              Amount
              
              Capital
              
              Compensation
              
              Earnings
              
              TotalBalance, December 31, 2006
              
              
              -
              
              
              -
              
              
              8,300,484
              
              
              8,300
              
              
              513,143
              
              
              (193,750
              )
              
              1,839,207
              
              
              2,166,900Shares issued for services
              
              
              -
              
              
              -
              
              
              100,000
              
              
              100
              
              
              219,900
              
              
              (165,001
              )
              
              -
              
              
              54,999Shares issued for Director Fees
              
              
              -
              
              
              -
              
              
              25,000
              
              
              25
              
              
              54,975
              
              
              -
              
              
              -
              
              
              55,000Options issued for services
              
              
              -
              
              
              -
              
              
              -
              
              
              
              
              
              5,990
              
              
              (2,996
              )
              
              -
              
              
              2,994Options issued to Directors
              
              
              -
              
              
              -
              
              
              -
              
              
              
              
              
              40,167
              
              
              (38,120
              )
              
              -
              
              
              2,047Options issued to Executive Directors
              
              
              -
              
              
              -
              
              
              -
              
              
              
              
              
              222,280
              
              
              (210,960
              )
              
              -
              
              
              11,320Deferred Compensation
              
              
              -
              
              
              -
              
              
              -
              
              
              
              
              
              -
              
              
              12,500
              
              
              -
              
              
              12,500Net (Loss)
              
              
              -
              
              
              -
              
              
              -
              
              
              
              
              
              -
              
              
              -
              
              
              (138,183
              )
              
              (138,183
              )Balance, March 31, 2007
              
              
              -
              
              $
              -
              
              $
              8,425,484
              
              $
              8,425
              
              $
              1,056,455
              
              $
              (598,327
              )
              $
              1,701,024
              
              $
              2,167,577








See
      accompanying notes to condensed consolidated financial statements.





F3






**AMERICAN
        SURGICAL HOLDINGS, INC. AND SUBSIDIARIES**
 **(formerly
        ASAH Corp.)**
 **CONDENSED
        CONSOLIDATED STATEMENTS OF CASH FLOWS**
 **FOR
        THE THREE MONTHS ENDED**
 **(UNAUDITED)**






MARCH
                  31, 2007
              
              MARCH
                  31, 2006**CASH
                  FLOWS FROM OPERATING ACTIVITIES:**Net
                  (loss) income
              
              $
              (138,183
              )
              $
              260,395Adjustments
                  to reconcile net (loss) income to net cash provided by (used in)
                  operating
                  activities:Depreciation
                  and amortization
              
              
              9,143
              
              
              6,592Deferred
                  Compensation
              
              
              12,500
              
              
              12,500Common
                  stock issued for services
              
              
              54,999
              
              
              -Common
                  stock issued for Director Fees
              
              
              55,000
              
              
              -Value
                  of options issued for services
              
              
              2,994
              
              
              -Value
                  of options issued to officers
              
              
              11,320
              
              
              -Value
                  of options issued for Director Fees
              
              
              2,047
              
              
              -Changes
                  in operating assets and liabilities:(Increase)
                  Decrease in accounts receivable
              
              
              12,922
              
              
              (11,139
              )(Increase)
                  Decrease in prepaid expenses and other current assets
              
              
              14,848
              
              
              4,086Increase
                  (Decrease) in accounts payable and accrued expenses
              
              
              62,193
              
              
              939Increase
                  (Decrease) in accrued taxes
              
              
              (491,059
              )
              
              168,174Net
                  Cash (Used In) Provided By Operating Activities
              
              
              (391,276
              )
              
              441,547**CASH
                  FLOWS FROM INVESTING ACTIVITIES:**Purchase
                  of property and equipment
              
              
              (7,766
              )
              
              (28,798
              )Net
                  Cash (Used In)Provided By Investing Activities
              
              
              (7,766
              )
              
              (28,798
              )**CASH
                  FLOWS FROM FINANCING ACTIVITIES**Bank
                  Overdraft
              
              
              -
              
              
              (35,352
              )Repayment
                  of loan payable - related party
              
              
              -
              
              
              (60,000
              )Net
                  Cash (Used In) Provided By Financing Activities
              
              
              -
              
              
              (95,352
              )**NET
                  INCREASE (DECREASE) IN CASH**
              
              
              (399,042
              )
              
              317,397**CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD**
              
              
              1,387,016
              
              
              133,193**CASH AND CASH EQUIVALENTS AT END OF PERIOD**
              
              $
              987,974
              
              $
              450,590**SUPPLEMENTAL
                  DISCLOSURE OF CASH FLOW INFORMATION:**Cash paid for income taxes
              
              $
              460,362
              
              $
              -Cash paid for interest expense
              
              $
              -
              
              $
              -










See
        accompanying notes to condensed consolidated financial statements.
   F4
  **AMERICAN
          SURGICAL HOLDINGS, INC. AND SUBSIDIARIES**
 **(formerly
          ASAH Corp.)**
 **NOTES
          TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**
 **AS
          OF MARCH 31, 2007AND DECEMBER 31, 2006**
 **(UNAUDITED)**
 
  **NOTE 1—** **BASIS OF PRESENTATION**
 
 The
          accompanying consolidated, condensed unaudited financial statements are
          presented in accordance with generally accepted accounting principles for
          interim financial information and the instructions to Form 10-QSB and item
          310
          under subpart A of Regulation S-B. Accordingly, they do not include all
          of the
          information and footnotes required by generally accepted accounting principles
          for complete financial statements. In the opinion of management, all adjustments
          (consisting only of normal occurring accruals) considered necessary in
          order to
          make the financial statements not misleading, have been included. The financial
          statements are presented on the accrual basis.
 
 These
          financial statements should be read in conjunction with the Company's audited
          financial statements and the accompanying notes included in the Company's
          Form
          10-KSB for the year ended December 31, 2006, filed with the SEC. The results
          of
          operations for the three month period ended March 31, 2007, are not necessarily
          indicative of the results to be expected for any subsequent quarter or
          for the
          entire fiscal year.
 
 **Use
          of estimates**
 
 The
          preparation of financial statements in conformity with U.S. GAAP requires
          management to make estimates and assumptions that affect the reported amounts
          of
          assets and liabilities and the disclosure of contingent assets and liabilities
          at the date of the financial statements and the reported amounts of revenues
          and
          expenses during the reporting period. Actual results could differ from
          those
          estimates.
 
 Significant
          estimates include revenue recognition, the allowance for doubtful accounts
          and
          share based compensation. These estimates have the potential to have a
          significant impact on our financial statements, either because of the
          significance of the financial statement item to which they relate, or because
          they require judgment and estimation due to the uncertainty involved in
          measuring, at a specific point in time, events which are continuous in
          nature.
 
 **Stock
          Consolidations**
 
 In
          January 2007, the Company completed a 1 for 1.75 common stock consolidation
          and
          in April 2007 the Company completed a 1 for 2 common stock consolidation.
          All
          share and per share amounts have been retroactively restated for the both
          the 1
          for 1.75 and the 1 for 2 stock consolidations.
  **Income
          taxes**
 
 The
          Company records deferred taxes in accordance with SFAS No. 109, *Accounting
          for Income Taxes* (“SFAS
          109”). The statement requires recognition of deferred tax assets and liabilities
          for temporary differences between the tax bases of assets and liabilities
          and
          the amounts at which they are carried in the financial statements, based
          upon
          the enacted tax rates in effect for the year in which the differences are
          expected to reverse. A valuation allowance is established when necessary
          to
          reduce deferred tax assets to the amount expected to be realized.
   F5
  **AMERICAN
          SURGICAL HOLDINGS, INC. AND SUBSIDIARIES**
 **(formerly
          ASAH Corp.)**
 **NOTES
          TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**
 **AS
          OF MARCH 31, 2007AND DECEMBER 31, 2006**
 **(UNAUDITED)**
 **Stock-based
          compensation**
 
 The
          Company accounts for its stock-based compensation under the provisions
          of SFAS
          No.123(R) *“Accounting
          for Stock Based Compensation.”* Under
          SFAS No. 123(R), the Company is permitted to record expenses for stock
          options and other employee compensation plans based on their fair value
          at the
          date of grant. Any such compensation cost is charged to expense on a
          straight-line basis over the periods the options vest. If the options had
          cashless exercise provisions, the Company utilized variable accounting.
 
 Common
          stock, stock options and common stock warrants issued to other than employees
          or
          directors are recorded on the basis of their fair value, as required by
          SFAS
          No. 123(R), which is measured as of the date required by EITF
          Issue 96-18, *“Accounting
          for Equity Instruments That Are Issued to Other Than Employees for Acquiring,
          or
          in Conjunction with Selling, Goods or Services* .”
In
          accordance with EITF 96-18, the stock options or common stock warrants are
          valued using the Black-Scholes model on the basis of the market price of
          the
          underlying common stock on the “valuation date,” which for options and warrants
          related to contracts that have substantial disincentives to non-performance
          is
          the date of the contract, and for all other contracts is the vesting date.
          Expense related to the options and warrants is recognized on a straight-line
          basis over the shorter of the period over which services are to be received
          or
          the vesting period. Where expense must be recognized prior to a valuation
          date,
          the expense is computed under the Black-Scholes model on the basis of the
          market
          price of the underlying common stock at the end of the period, and any
          subsequent changes in the market price of the underlying common stock up
          through
          the valuation date is reflected in the expense recorded in the subsequent
          period
          in which that change occurs.
 
 In
          December 2002, the Financial Accounting Standards Board (“FASB”) issued
          SFAS No. 148, *“Accounting
          for Stock-Based Compensation-Transition and Disclosure”.* SFAS
          No. 148 also amends the disclosure requirements of SFAS No. 123(R),
          requiring prominent disclosure in annual and interim financial statements
          regarding a company’s method for accounting for stock-based employee
          compensation and the effect of the method on reported results.
 
 Compensation
          expense was recognized in connection with the issuance of stock options
          to
          non-employee consultants in accordance with EITF 96-18, “Accounting for Equity
          Instruments That are Issued to Other than Employees for Acquiring, or in
          Conjunction with Selling Goods and Services.” SFAS No. 123(R) did not
          change the accounting for stock-based compensation related to non-employees
          in
          connection with equity based incentive arrangements.
 
 The
          fair
          market value of the stock options at the date of grant was estimated using
          the
          Black-Scholes option-pricing model with the following assumptions:
  Expected
                      Life
                  3
                      to 5 yearsInterest
                      Rate
                  4.25%Dividend
                      Yield
                  $0Volatility
                  28%Forfeiture
                      Rate
                  0
  Expected
          life represents the period of time that options are expected to be outstanding
          and is based on the Company’s historical experience or the simplified method, as
          permitted by SEC Staff Accounting Bulletin No. 107 where appropriate. The
          risk-free interest rate is based on U.S. Treasury interest rates at the
          time of
          the grant whose term is consistent with the expected life of the stock
          options.
   F6
  **AMERICAN
            SURGICAL HOLDINGS, INC. AND SUBSIDIARIES**
 **(formerly
            ASAH Corp.)**
 **NOTES
            TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**
 **AS
            OF MARCH 31, 2007AND DECEMBER 31, 2006**
 **(UNAUDITED)**
 Expected
          dividend yield was considered to be $0 in the option pricing formula since
          the Company
          does not pay dividends and has no current plans to do so in the future.
          Expected
          volatility is based on the Company’s historical experience. The forfeiture rate
          was considered to be none insofar as the historical experience of the Company
          is
          very limited. As required by SFAS No. 123(R), the Company will adjust the
          estimated forfeiture rate based upon actual experience.
 
 **Basic
                    and Diluted Net Income (Loss) Per Share**The
                    Company computes net income (loss) per share in accordance with
                    SFAS No.
                    128, "*Earnings
                    per Share*".
                    SFAS No. 128 requires presentation of both basic and diluted
                    earnings per
                    share (EPS) on the face of the income statement. Basic EPS is
                    computed by
                    dividing net income (loss) available to common shareholders (numerator)
                    by
                    the weighted average number of shares outstanding (denominator)
                    during the
                    period. Diluted EPS gives effect to all dilutive potential common
                    shares
                    outstanding during the period using the treasury stock method and
                    convertible preferred stock using the if-converted method. In
                    computing
                    diluted EPS, the average stock price for the period is used in
                    determining
                    the number of shares assumed to be purchased from the exercise
                    of stock
                    options or warrants. Diluted EPS excludes all dilutive potential
                    shares if
                    their effect is anti dilutive. As of March 31, 2006 the Company
                    does not
                    have any dilutive securities outstanding. The 1,105,000 outstanding
                    stock
                    options and warrants at March 31, 2007 were excluded from the
                    computation
                    of diluted earnings per share because their effect was anti-dilutive.
 
 **Recent
          accounting pronouncements**
 
 In
          July
          2006, the FASB issued FASB Interpretation No. 48, *Accounting
          for Uncertainty in Income Taxes - an Interpretation of FASB Statement No.
          109* (“FIN
          48”). FIN 48 is intended to reduce the diversity encountered in practice with
          regard to certain aspects of the recognition and measurement related to
          accounting for income taxes, and to clarify the accounting and disclosure
          for
          uncertainty in tax positions. FIN 48 introduces a new and more comprehensive
          model of accounting and reporting for a number of tax positions routinely
          taken
          by corporations when filing their tax returns. FIN 48 prescribes a recognition
          threshold of more-likely-than-not, and a measurement attribute for all
          tax
          positions taken or expected to be taken on a tax return, in order for those
          tax
          positions to be recognized in the financial statements. Effective
          January 1, 2007, we adopted the provisions of FIN 48 and there was no
          material effect on the financial statements. As a result, there was no
          cumulative effect related to adopting FIN 48.
 
 In
          September 2006, the FASB issued SFAS No. 157, *Fair
          Value Measurements* (“SFAS
          No. 157”). SFAS No. 157 defines fair value, establishes a framework for
          measuring fair value under GAAP, expands the required disclosures regarding
          fair
          value measurements, and applies to other accounting pronouncements that
          either
          require or permit fair value measurements. SFAS No. 157 is effective for
          fiscal
          years beginning after November 15, 2007, and for interim periods within
          those
          fiscal years, with early adoption encouraged. SFAS No. 157 is to be applied
          prospectively, with a limited form of retrospective application for several
          financial instruments. The Company plans to adopt SFAS No. 157 on January
          1,
          2007, and currently believes that its adoption will not have a material
          effect
          on the Company’s financial position, operations or cash flows.
 
 In
          February 2007, the FASB issued SFAS No. 159, *The
          Fair Value Option for Financial Assets and Financial
          Liabilities* .
          SFAS
          No. 159 allows a company to choose to measure many financial assets and
          financial liabilities at fair value. Unrealized gains and losses on items
          for
          which the fair value option has been elected are reported in earnings.
          SFAS No.
          159 is effective for fiscal years beginning after November 15,
          2007.
   F7
   **AMERICAN
            SURGICAL HOLDINGS, INC. AND SUBSIDIARIES**
 **(formerly
            ASAH Corp.)**
 **NOTES
            TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**
 **AS
            OF MARCH 31, 2007AND DECEMBER 31, 2006**
 **(UNAUDITED)**
  Therefore,
          the Company is required to adopt SFAS No. 159 by the first quarter of 2008.
          The
          Company is currently evaluating the requirements of SFAS No. 159 and the
          potential impact on the Company’s financial statements.
 
 In
          September 2006, the SEC issued Staff Accounting Bulletin No. 108, *Considering
          the Effects of Prior Year Misstatements when Quantifying Misstatements
          in
          Current Year Financial Statements* (“SAB
          No.
          108”). SAB No. 108 provides guidance in considering the effects of prior year
          misstatements in the quantification of current year misstatements, for
          the
          purpose of determining whether the current year’s financial statements are
          materially misstated. SAB No. 108 is effective for fiscal years ending
          after
          November 15, 2006. The adoption of SAB No. 108 has not had a material impact
          on
          the Company’s financial position, operations or cash flows.
 
 In
          December 2006, the FASB issued FASB Staff Position No. EITF 00-19-2, *Accounting
          for Registration Payment Arrangements* (“FSP
          EITF 00-19-2”). FSP EITF 00-19-2 clarifies that a registration payment
          arrangement and the financial instrument(s) relating to that arrangement
          should
          be separately measured and recognized in an entity’s financial statements,
          according to the appropriate GAAP for each, rather than treated as a unit.
          Specifically, FSP EITF 00-19-2 states that the financial instrument(s)
          should be
          recorded in the financial statements using appropriate GAAP without regard
          to
          contingent obligations in respect of a registration payment arrangement.
          FSP
          EITF 00-19-2 is effective immediately for registration payment arrangements
          and
          related financial instruments that are entered into or modified after December
          21, 2006. For registration payment arrangements and related financial
          instruments that were entered into prior to December 21, 2006, and that
          continue
          to be outstanding at the beginning of the period of adoption, transition
          is to
          be achieved by reporting a change in accounting principle through a
          cumulative-effect adjustment to the opening balance of retained earnings
          as of
          the first interim period for the fiscal year in which FSP EITF 00-19-2
          is
          adopted. Early adoption of FSP EITF 00-19-2 is permitted for interim or
          annual
          periods for which financial statements or interim reports have not been
          issued.
          Retrospective application is not permitted. The Company has chosen to adopt
          FSP
          EITF 00-19-2 in the fourth quarter of the year ending December 31, 2006.
          The
          Company’s adoption of EITF 00-19 in 2006 has not had a material effect on its
          financial position, operations or cash flow.
 
 
 **NOTE
          2 - EQUITY**
 
 In
          January 2007, the Company entered into a six-month agreement with Hawk
          Associates, Inc. to provide investor relations services for the Company.
          In
          addition to monetary compensation, the Company granted the investor relations
          firm 30,000 warrants to purchase shares of the Company’s common stock at a price
          of $3.10 per share with a life of 5 years. The value of these warrants
          was
          determined by management using the Black-Scholes option pricing model to
          be
          $5,990.
 
 In
          January 2007, the Company renewed for a one-year term an agreement for
          strategic
          planning and consulting services with Global Business Resources. In addition
          to
          monetary compensation, the Company granted the consulting firm 100,000
          shares of
          common stock. The value of this grant of stock was determined by management
          to
          be $220,000 based on the fair value of the stock on the date of the grant.
          Such
          shares were issued in reliance on an exemption from registration under
          Section
          4(2) of the Securities Act of 1933. No placement agent was used for this
          transaction.
   F8
  **AMERICAN
            SURGICAL HOLDINGS, INC. AND SUBSIDIARIES**
 **(formerly
            ASAH Corp.)**
 **NOTES
            TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**
 **AS
            OF MARCH 31, 2007AND DECEMBER 31, 2006**
 **(UNAUDITED)**
  In
          March
          2007, Mr. Elgama **l** and Mr. Olmo-Rivas
          were each granted 500,000 options to purchase the Company’s common stock. These
          options vest ratably over 3 years. The value of these options was determined
          by
          management using the Black-Scholes option pricing model to be
          $222,280.
 
 In
          March
          2007, the Company issued 25,000 shares of common stock to Henry Y. L. Toh
          as
          part of his inaugural Director Fees. The Company valued these shares at
          $55,000
          based on the fair value of the stock on the date of grant. Such
          shares were issued in reliance on an exemption from registration under
          Section
          4(2) of the Securities Act of 1933. No placement agent was used for this
          transaction.
 
 Additionally,
          as part of his inaugural Director Fees, Mr. Toh was issued 75,000 stock
          options
          to purchase the Company’s common stock. The options vest ratably over 3 years.
          The value of these options was determined by management using the Black-Scholes
          option pricing model to be $40,166.
 
 **NOTE
          3 - SUBSEQUENT EVENTS**
 
 In
          April
          2007, the Company issued 25,000 options to purchase the Company’s common stock
          to Dr. Bailey and 25,000 options to Dr. Kleinman as Director Fees. The
          value of
          these options was determined by management using the Black-Scholes option
          pricing model to be $30,278.
 
 In
          May
          2007, the Company entered into a one-year agreement with Equity Communications
          LLC (“EC”) to act as the Company’s Financial Public Relations Counsel. Under the
          terms of the contract, the Company will pay EC monetary compensation and
          the
          Company granted EC 128,000 options to purchase the Company’s common stock. The
          options vest over the one-year period of the contract. The Company has
          the right
          to cancel all but 25,600 options at its discretion prior to November 1,
          2007.
          The value of the first group of options was determined by management using
          the
          Black-Scholes option pricing model to be $14,993.
 
 In
          May
          2007 the Company engaged Dawson James Securities, Inc. (“Dawson James”) to act
          as its exclusive placement agent in connection with the offering, issuance
          and
          sale by the Company of up to 25 Units. Each Unit shall consist of: (i)
          an 15%
          interest bearing unsecured promissory note in the principal amount of $100,000
          payable in cash at the Maturity Date and (ii) a five-year warrant to purchase
          100,000 shares of the Company’s common stock at an exercise price of $2.00 per
          share. For its’ services Dawson James will earn a commission equal to 10% of the
          price of each Unit sold, plus cashless warrants to purchase 20,000 shares
          of our
          common stock for each Unit sold. They will also receive a nonaccountable
          expense
          allowance equal to 3% of the purchase price of each Unit
          sold.


F9





**Item
      2. Management’s Discussion and Analysis of Financial Condition and Results of
      Operations**




**FORWARD-LOOKING
      STATEMENTS**





*This
      report contains certain “forward-looking statements” within the meaning of
      Section 27A of the Securities Act of 1933, as amended, and Section 21E
      of the Exchange Act of 1934, as amended, which are based on management’s
      exercise of business judgment as well as assumptions made by and information
      currently available to, management. When used in this document, the words “may”,
“will”, “anticipate”, “believe”, “estimate”, “expect”, “intend” and words of
      similar import, are intended to identify any forward-looking statements. You
      should not place undue reliance on these forward-looking statements. These
      statements reflect our current view of future events and are subject to certain
      risks and uncertainties as described in this Report on Form 10-QSB as well
      as
      other periodic reports, filed with the Securities and Exchange Commission,
      and
      as noted below. Should one or more of these risks or uncertainties materialize,
      or should underlying assumptions prove incorrect, our actual results could
      differ materially from those anticipated in these forward-looking statements.
      We
      undertake no obligation, and do not intend, to update, revise or otherwise
      publicly release any revisions to these forward-looking statements to reflect
      events or circumstances after the date hereof, or to reflect the occurrence
      of
      any unanticipated events. Although we believe that our expectations are based
      on
      reasonable assumptions, we can give no assurance that our expectations will
      materialize.*





GENERAL




We
      were
      incorporated in the State of Delaware under the name Renfrew, Inc. on July
      22,
      2003 as a blank check company as defined under Rule 419 of the Securities Act.
      On August 2, 2005, we filed Articles of Amendment with the State of Delaware
      changing our name to ASAH Corp. and on January 9, 2007, we filed Articles of
      Amendment with the State of Delaware changing our name to American Surgical
      Holdings, Inc.





Pursuant
      to a Stock Purchase Agreement and Share Exchange between us and American
      Surgical Assistants, Inc. dated October 10, 2005, we acquired all of the shares
      of American Surgical Assistants, Inc., a Texas corporation, from Zak Elgamal
      and
      Jaime Olmo-Rivas. As a result of and in consideration for the issuance of
      1,714,286 shares of our common stock to Mr. Elgamal and 1,714,286 shares of
      our common stock to Mr. Olmo-Rivas for an aggregate amount of 3,428,572
      shares of our common stock, American Surgical Assistants, Inc. became our wholly
      owned subsidiary.





We
      had
      operated as a blank check company until the merger in October 2005 and the
      purpose for this reorganization with American Surgical Assistants, Inc. was
      to
      obtain an operating company which we believed has a successful business plan.
      Now, through American Surgical Assistants, Inc., we provide professional
      surgical assistant services to patients, surgeons and healthcare institutions.





In
      2006
      we incorporated our other subsidiary, ATS Billing Services, Inc. (“ATS”) to
      provide HIPAA-compliant billing and collection services for healthcare industry
      professionals.





In
      January 2007, the Company completed a 1 for 1.75 common stock consolidation
      and
      in April 2007 the Company completed a 1 for 2 common stock consolidation. All
      share and per share amounts have been retroactively restated for the both the
      1
      for 1.75 and the 1 for 2 stock consolidations.




RESULTS
      OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2007 COMPARED TO THE THREE
      MONTHS ENDED MARCH 31, 2006







Revenues




Net
      Revenues increased by 15% for the three months ended March 31, 2007 over the
      same period ended March 31, 2006. Approximately 7% of the growth was as a result
      of our Houston operations. We expanded our roster of healthcare facilities
      served during the previous year and continued to see results therefrom. We
      worked to maintain and enhance our existing relationships with surgeons,
      hospital and healthcare facility clients in the Houston market. We also
      developed new clients in our home base of Houston, resulting in an increase
      in
      new business and thereby increased our net revenues. The remaining approximate
      8% of the growth was as a result of our expansion into the Corpus Christi,
      Texas
      market in November 2006. We are pleased with the early results from Corpus
      and
      expect that this is only the first stage of our overall plan to establish
      operations in other Texas urban centers over the next several
      months.




Costs
      of
      Revenue




Although
      our Net Revenues increased by 15% as discussed above, our Costs of Revenues
      (“COR”) grew by only 5%. COR includes those expenses that are directly related
      to the surgical assistants and the performance of their services. We continue
      to
      see increases in such items as salaries, contract services, telephone and pager
      expense but the growth has been managed more effectively over the last several
      months. We have begun to develop more effective controls over these costs.
      As we
      are better able to manage these costs we expect to see our gross margins and
      overall profitability increase in the future as a result of these
      efforts.




Gross
      Profit





As
        a
        result of the interplay between higher revenues and lower COR we increased
        our
        Gross Profits to 37% during the first quarter 2007 compared to 31% for the
        first
        quarter 2006.




Operating
      Expenses





The
      ongoing process of creating a Board of Directors as well as other costs
      associated with registering our stock and going public impacted operating
      expenses for the three months ended March 31, 2007. We incurred certain one-time
      costs setting up and paying our initial Board of Directors, hiring public
      relations firms and in legal, professional and consulting fees during the first
      quarter of 2007. We also saw an increase in costs and expenses as we hired
      administrative and other support personnel. Our anticipated growth, both
      internal and through acquisition/merger, creates a need for us to adequately
      staff our home office so that we can effectively manage and properly control
      our
      operations.




Operating
      Results as a Percentage of Net Revenue





The
      Table
      below provides a brief recap of operating results for the three months ended
      March 31, 2007 and 2006 expressed as a percentage of Net Revenue.











March
                31,
            
            March
                31,2007
            
            2006Net
                Revenue
            
            
            100.00
            %
            
            100.00
            %Cost
                of Revenues
            
            
            62.17
            %
            
            68.29
            %Gross
                Profit
            
            
            37.83
            %
            
            31.71
            %Operating
                Expenses
            
            
            44.61
            %
            
            12.36
            %Net
                (Loss) Income from Operations
            
            
            (6.78
            %)
            
            19.35
            %Other
                Income
            
            
            0.21
            %
            
            0.04
            %(Loss)
                Income from Operations
            
            
            (6.57
            %)
            
            19.39
            %Provision
                for Income Taxes
            
            
            (1.20
            %)
            
            7.75
            %Net
                (Loss) Income
            
            
            (5.37
            %)
            
            11.65
            %






LIQUIDITY
      AND CAPITAL RESOURCES




Operating
      Activities.




As
      of
      March 31, 2007, we had $987,974 in cash and cash equivalents on hand.
      Historically, our principal working capital needs have been met through
      continuing operations. As the Company grows and looks to expand our operations,
      our need for working capital will increase. We plan to utilize cash from
      operations as well as other sources such as borrowings and the sale of equities,
      specifically our common stock. We expect to be able to finance future
      acquisitions with cash provided from operations, borrowings, debt or equity
      offerings, or some combination thereof.




Our
      operating activities used cash of $391,276 during the first quarter of 2007
      compared to cash provided by operations of $441,547 for the same period in
      2006.
      As of March 31, 2007, we had total current assets of $3,053,875 compared to
      current liabilities of $987,050.




During
      March 2007 the Company paid $460,362 to the IRS for its’ 2006 tax liability.
      This amount had been previously recorded as part of our deferred tax
      provision.












Critical
      Accounting Policies





Our
        significant accounting policies are summarized in Note 1 of our Condensed
        Consolidated Financial Statements included herein. Policies determined to
        be
        significant are those policies that have the greatest impact on our financial
        statements and require management to use a greater degree of judgment and
        estimates. Actual results may differ from those estimates. Our management
        believes that given current facts and circumstances, it is unlikely that
        applying any other reasonable judgments or estimate methodologies would cause
        effect on our consolidated results of operations, financial position or
        liquidity for the periods presented in this report.
 
 The
        preparation of financial statements in conformity with U.S. GAAP requires
        management to make estimates and assumptions that affect the reported amounts
        of
        assets and liabilities and the disclosure of contingent assets and liabilities
        at the date of the financial statements and the reported amounts of revenues
        and
        expenses during the reporting period. Actual results could differ from those
        estimates.
 
 Significant
        estimates include revenue recognition, the allowance for doubtful accounts
        and
        share based compensation. These estimates have the potential to have a
        significant impact on our financial statements, either because of the
        significance of the financial statement item to which they relate, or because
        they require judgment and estimation due to the uncertainty involved in
        measuring, at a specific point in time, events which are continuous in
        nature.


Recent
      Accounting Pronouncements




In
      July
      2006, the FASB issued FASB Interpretation No. 48, *Accounting
      for Uncertainty in Income Taxes - an Interpretation of FASB Statement No. 109* (“FIN
      48”). FIN 48 is intended to reduce the diversity encountered in practice with
      regard to certain aspects of the recognition and measurement related to
      accounting for income taxes, and to clarify the accounting and disclosure for
      uncertainty in tax positions. FIN 48 introduces a new and more comprehensive
      model of accounting and reporting for a number of tax positions routinely taken
      by corporations when filing their tax returns. FIN 48 prescribes a recognition
      threshold of more-likely-than-not, and a measurement attribute for all tax
      positions taken or expected to be taken on a tax return, in order for those
      tax
      positions to be recognized in the financial statements. Effective
      January 1, 2007, we adopted the provisions of FIN 48 and there was no
      material effect on the financial statements. As a result, there was no
      cumulative effect related to adopting FIN 48.




In
      September 2006, the FASB issued SFAS No. 157, *Fair
      Value Measurements* (“SFAS
      No. 157”). SFAS No. 157 defines fair value, establishes a framework for
      measuring fair value under GAAP, expands the required disclosures regarding
      fair
      value measurements, and applies to other accounting pronouncements that either
      require or permit fair value measurements. SFAS No. 157 is effective for fiscal
      years beginning after November 15, 2007, and for interim periods within those
      fiscal years, with early adoption encouraged. SFAS No. 157 is to be applied
      prospectively, with a limited form of retrospective application for several
      financial instruments. The Company plans to adopt SFAS No. 157 on January 1,
      2007, and currently believes that its adoption will not have a material effect
      on the Company’s financial position, operations or cash flows.




In
      February 2007, the FASB issued SFAS No. 159, *The
      Fair Value Option for Financial Assets and Financial
      Liabilities* .
      SFAS
      No. 159 allows a company to choose to measure many financial assets and
      financial liabilities at fair value. Unrealized gains and losses on items for
      which the fair value option has been elected are reported in earnings. SFAS
      No.
      159 is effective for fiscal years beginning after November 15, 2007.
      Therefore, the Company is required to adopt SFAS No. 159 by the first quarter
      of
      2008. The Company is currently evaluating the requirements of SFAS No. 159
      and
      the potential impact on the Company’s financial statements.




In
      September 2006, the SEC issued Staff Accounting Bulletin No. 108, *Considering
      the Effects of Prior Year Misstatements when Quantifying Misstatements in
      Current Year Financial Statements* (“SAB
      No.
      108”). SAB No. 108 provides guidance in considering the effects of prior year
      misstatements in the quantification of current year misstatements, for the
      purpose of determining whether the current year’s financial statements are
      materially misstated. SAB No. 108 is effective for fiscal years ending after
      November 15, 2006. The adoption of SAB No. 108 has not had a material impact
      on
      the Company’s financial position, operations or cash flows.















In
      December 2006, the FASB issued FASB Staff Position No. EITF 00-19-2, *Accounting
      for Registration Payment Arrangements* (“FSP
      EITF 00-19-2”). FSP EITF 00-19-2 clarifies that a registration payment
      arrangement and the financial instrument(s) relating to that arrangement should
      be separately measured and recognized in an entity’s financial statements,
      according to the appropriate GAAP for each, rather than treated as a unit.
      Specifically, FSP EITF 00-19-2 states that the financial instrument(s) should
      be
      recorded in the financial statements using appropriate GAAP without regard
      to
      contingent obligations in respect of a registration payment arrangement. FSP
      EITF 00-19-2 is effective immediately for registration payment arrangements
      and
      related financial instruments that are entered into or modified after December
      21, 2006.




For
      registration payment arrangements and related financial instruments that were
      entered into prior to December 21, 2006, and that continue to be outstanding
      at
      the beginning of the period of adoption, transition is to be achieved by
      reporting a change in accounting principle through a cumulative-effect
      adjustment to the opening balance of retained earnings as of the first interim
      period for the fiscal year in which FSP EITF 00-19-2 is adopted. Early adoption
      of FSP EITF 00-19-2 is permitted for interim or annual periods for which
      financial statements or interim reports have not been issued. Retrospective
      application is not permitted. The Company has chosen to adopt FSP EITF 00-19-2
      in the fourth quarter of the year ending December 31, 2006. The Company’s
      adoption of EITF 00-19 in 2006 has not had a material effect on its financial
      position, operations or cash flow.




Off-Balance
      Sheet Arrangements




We
      have
      no significant off-balance sheet arrangements that have or are reasonably likely
      to have a current or future effect on our financial condition, changes in
      financial condition, revenues or expenses, results of operations, liquidity,
      capital expenditures or capital resources that is material to
      stockholders.




**Item
      3. Controls and Procedures**




Under
      the
      supervision and with the participation of our management, including our
      principal executive officer and principal financial officer, we conducted an
      evaluation of our disclosure controls and procedures, as such term is defined
      under Rule 13a-15(e) and Rule 15d-15(e) promulgated under the Securities
      Exchange Act of 1934, as amended (Exchange Act), as of March 31, 2007. Based
      on
      this evaluation, our principal executive officer and principal financial officer
      have concluded that our disclosure controls and procedures are effective to
      ensure that information required to be disclosed by us in the reports we file
      or
      submit under the Exchange Act is recorded, processed, summarized, and reported
      within the time periods specified in the Securities and Exchange Commission’s
      rules and forms and that our disclosure and controls are designed to ensure
      that
      information required to be disclosed by us in the reports that we file or submit
      under the Exchange Act is accumulated and communicated to our management,
      including our principal executive officer and principal financial officer,
      or
      persons performing similar functions, as appropriate to allow timely decisions
      regarding required disclosure.




There
      were no changes (including corrective actions with regard to significant
      deficiencies or material weaknesses) in our internal controls over financial
      reporting that occurred during the first quarter of fiscal 2007 that has
      materially affected, or is reasonably likely to materially affect, our internal
      control over financial reporting.










**PART
      II - OTHER INFORMATION**




**Item
      1. Legal Proceedings.**




Currently
      we are not aware of any litigation pending or threatened by or against the
      Company.







**Item
      2. Unregistered Sales of Equity Securities and Use of
      Proceeds**





In
      January 2007, the Company entered into a six-month agreement with Hawk
      Associates, Inc. to provide investor relations services for the Company. In
      addition to monetary compensation, the Company granted the investor relations
      firm 30,000 warrants to purchase shares of the Company’s common stock at a price
      of $3.10 per share with a life of 5 years. The value of these warrants was
      determined by management using the Black-Scholes option pricing model to be
      $5,990.





In
      January 2007, the Company renewed for a one-year term an agreement for strategic
      planning and consulting services with Global Business Resources. In addition
      to
      monetary compensation, the Company granted the consulting firm 100,000 shares
      of
      common stock. The value of this grant of stock was determined by management
      to
      be $220,000 based on the fair value of the stock on the date of grant. Such
      shares were issued in reliance on an exemption from registration under Section
      4(2) of the Securities Act of 1933.





In
      March
      2007, Mr. Elgamal and Mr. Olmo-Rivas
      were each granted 500,000 options to purchase the Company’s common stock. These
      options vest ratably over 3 years. The value of these options was determined
      by
      management using
      the
      Black-Scholes option pricing model to be
      $222,280.





In
      March
      2007, the Company issued 25,000 shares of common stock to Henry Y. L. Toh as
      part of his inaugural Director Fees. The Company valued these shares at $55,000
      based on the fair value of the stock on the date of grant. Such
      shares were issued in reliance on an exemption from registration under Section
      4(2) of the Securities Act of 1933.





Additionally,
      as part of his inaugural Director Fees, Mr. Toh was issued 75,000 stock options
      to purchase the Company’s common stock. The options vest ratably over 3 years.
      The value of these options was determined by management using
      the
      Black-Scholes option pricing model **** to
      be
      $40,166.





**Item
      3. Defaults Upon Senior Securities.**




None




**Item
      4. Submission of Matters to a Vote of Security Holders.**




Board
      of
      Directors





On
      or
      about March 23, 2007, the Majority Stockholders approved the appointment of
      Jaime Olmo-Rivas, Henry Y. L. Toh, Dr. Charles W. Bailey, Jr., and Dr. Michael
      Kleinman to the Company’s Board of Directors to hold office until the next
      annual stockholder’s meeting in accordance with the Delaware Business
      Corporation Act. Below are the names and profiles of our independent directors
      and their business experience during at least the last five years.










**Name**
            **Age**
            **Position**Zak
                W. Elgamal
            58
            Executive
                Chairman, Chief Executive Officer and PresidentJaime
                Olmo-Rivas
            51
            Executive
                Director, and Vice President of American Surgical Assistants,
                Inc.Henry
                Y. L. Toh
            49
            Lead
                Independent DirectorDr.
                Charles W. Bailey, Jr
            66
            Independent
                DirectorDr.
                Michael Kleinman
            51
            Independent
                Director





**Henry
      Y.L. Toh, Lead Independent Director**





Mr.
      Toh
      currently serves as a member of the Board of Directors for other publicly traded
      companies. Since 2001, Mr. Toh has served as a director of Teletouch
      Communications Inc. Since 1992, Mr. Toh has served as an officer and director
      of
      C2 Global Technologies Inc., a publicly held voice-over-IP company. Since
      December 1998, Mr. Toh has served as a director of Idna Inc., a specialized
      finance and entertainment company. Since 2004, Mr. Toh has served as a director
      of Isolagen, Inc. Mr. Toh has served as an officer and director of Four M
      International, Inc., a privately held offshore investment entity since 1992,
      Since 2004, Mr. Toh has served as a director of Labock Technologies, Inc. Mr.
      Toh began his career with KPMG Peat, Marwick from 1980 to 1992, where he
      specialized in international taxation and mergers and acquisitions. Mr. Toh
      is a
      graduate of Rice University





**Charles
      W. Bailey, JR., MD, JD, Director**




Dr.
      Bailey **** received
      his law degree from the South Texas School of Law in 1980 and received his
      Medical Degree from the University of Texas Medical Branch. Dr. Bailey has
      been
      in private practice in plastic surgery since 1973. He is listed in Best Doctors
      in America for the Central Region and was named by Town & Country Magazine
      as one of the top Cosmetic Surgeons in the United States. From 1980 to the
      present, Dr. Bailey has also been a medicolegal consultant to various law firms
      and insurance companies, providing medical record review and evaluations. From
      1972 through 1993, he held various teaching appointments with the University
      of
      Texas Medical School in Houston, South Texas College of Law, and Baylor College
      of Medicine. Dr. Bailey has published over 45 papers, and has held various
      positions, including most recently President of the Texas Medical Association
      in
      2003 and 2004. He is a current Delegate to the American Medical Association.
      Dr.
      Bailey is also a member of the Mediation Panel for Federal District Courts,
      Southern District of Texas.










**Dr.
      Michael Kleinman, Director**





Dr.
      Kleinman graduated from Rice University, attained his medical degree at the
      University of Texas, Albert Einstein College of Medicine in Dallas, Texas in
      1983. He is a Board certified surgeon with a private practice in Houston,
      Texas, Clinical Assistant Professor of Surgery at Baylor University and at
      the University of Texas, Physician Liaison for Memorial Care System. Fellow
      of
      the American College of Surgeons, , Member of the American Society of General
      Surgeons, the Society of American Gastrointestinal Laparoscopic Surgery, Houston
      Surgical Society, Harris County Medical Society, and the American Medical
      Association. Past member of Texas Medical Association, International College
      of
      Surgeons, American College of Physician Executives, and the American Board
      of
      Utilization Review Physicians.  Physicians Recognition Award 2003, 2006, 10
      citations for top doctors.




**Item
      5. Other Information.**




None




**Item
      6. Exhibits and Reports of Form 8-K.**




(a)
            Exhibits




31.1
                Certifications pursuant to Section 302 of Sarbanes Oxley Act of
                2002




32.1
                Certifications pursuant to Section 906 of Sarbanes Oxley Act of
                2002





(b)
            Reports
                of Form 8-K




On
                February 7, 2007, we filed an 8-K for a letter of intent with Dawson
                James
                Securities, Inc. as the lead underwriter for a public offering of
                units of
                the Company’s securities.



















**SIGNATURES**




Pursuant
      to the requirements of the Securities Exchange Act of 1934, as amended, the
      registrant caused this report to be signed on its behalf by the undersigned,
      thereunto duly authorized.








AMERICAN
      SURGICAL HOLDINGS, INC.


Date:
                May 14, 2007
            By:
            /s/*ZAK
                W. ELGAMAL*Zak
                W. ElgamalChairman
                & Chief Executive OfficerDate:
                May 14, 2007
            By:
            /s/*WILLIAM
                J. MCGINNIS*William
                J. McGinnisActing
                Chief Accounting Officer